Omeros Corporation Soared
Fri, Nov 14, 2025 at 07:14 PM
Omeros Corporation (OMER:NASDAQ) jumped higher at $7.87, representing a gain of 25.3%. On Fri, Nov 14, 2025, OMER:NASDAQ hit a New 2-Week High of $7.87. The stock appeared on our News Catalysts scanner on Thu, Nov 13, 2025 at 04:50 PM in the 'EARNINGS' category. From Fri, Oct 31, 2025, the stock recorded 50.00% Up Days and 36.36% Green Days
The stock spiked on Wed, Oct 15, 2025 at $12.1 with a volume of 125M+.
About Omeros Corporation (OMER:NASDAQ)
Omeros Corp is a biopharmaceutical company. It focuses on research and development of small-molecule and protein therapeutics to treat inflammation, coagulopathies, and disorders of the central nervous system and sells Omidria for cataract surgeries.
Top 10 Gainers:
- Leap Therapeutics, Inc. (LPTX:NASDAQ), 368.57%
- Cidara Therapeutics, Inc. (CDTX:NASDAQ), 105.41%
- Cypherpunk Technologies Inc Com (New) (CYPH:NASDAQ), 56.25%
- Cycurion, Inc. (CYCU:NASDAQ), 51.2%
- Invivyd, Inc. (IVVD:NASDAQ), 32.77%
- The Oncology Institute, Inc. (TOI:NASDAQ), 28.9%
- NOMADAR Corp. (NOMA:NASDAQ), 26.46%
- Connect Biopharma Holdings Limited (CNTB:NASDAQ), 26.19%
- Precigen, Inc. (PGEN:NASDAQ), 25.65%
- Omeros Corporation (OMER:NASDAQ), 25.32%